Navigation Links
Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
Date:5/8/2009

betes classified from normotension to hypertension, and to test whether this extensive subgrouping might provide additional insight for practicing physicians.

"It is essential to manage blood pressure very aggressively in diabetics because their heart attack and stroke rates are more closely related to their blood pressure levels than to their blood sugar levels," said Joseph L. Izzo, Jr., M.D., Professor of Medicine and Pharmacology at SUNY-Buffalo and Director of Medicine at the Erie County Medical Center in Buffalo. "In ROADMAP, to date, we have achieved some of the lowest BP levels ever in a clinical trial.

About ROADMAP

ROADMAP is a randomized, double-blind, placebo-controlled, parallel-group, multi-center Phase III study being conducted at 262 collaborating centers in 19 European countries. The primary goal of the study is to test the hypothesis that treatment of T2DM patients with 40 mg of olmesartan medoxomil will prevent or delay the occurrence of microalbuminuria in comparison to a regimen that excludes agents that directly block the RAS. The secondary objective is to test the hypothesis that treatment with olmesartan medoxomil has a positive effect on cardiovascular and renal morbidity and mortality.

The study involves 4,449 men and women with T2DM with normoalbuminuria (less than or equal to 35 mg albumin/g urine creatinine for women and less than or equal to 25 mg albumin/g urine creatinine for men) at the outset, and who have at least one additional cardiovascular risk factor, including patients being treated for hypertension. Patients were randomized to receive 40 mg of olmesartan medoxomil or placebo for an average of five years. Patients with hypertension were also treated at the investigator's discretion with diuretics, alpha- or beta-blockers or calcium channel antagonists to achieve a target BP of <130/80. Patients requiring treatment with an ARB or ACEi were withdr
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation
4. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
5. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
6. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
7. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
8. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
9. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
10. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
11. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/7qn2gf/global_insulin ) ... Insulin Patch Market Opportunity Analysis" report to ... ultrasound and iontophoresis are being used for the ... type of technique, their prices may vary which ... In long-term, it would be considered as inexpensive ...
(Date:5/6/2015)... 6, 2015 NVSSoft, a ... named a "Cool Vendor" by top IT research firm Gartner ... Gartner defines a "Cool Vendor" as a company ... intriguing. The report highlights that, "as innovation gains ... emerging markets should look at local technologies and services, which ...
(Date:5/6/2015)... , May 6, 2015 ... significantly expanded its process for helping pharmaceutical companies ... patient access. The newly expanded ... services will go beyond helping companies develop and ... process to identify and engage critical stakeholders earlier ...
Breaking Medicine Technology:Global Insulin Patch Market Opportunity Analysis 2015 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 43D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 23D Communications Expands Market Access and Reimbursement Communications Services for Pharmaceutical Companies 3
(Date:5/7/2015)... May 07, 2015 When people think about ... consideration to their roofs than their basements. However, heavy rain ... in crawlspaces and basements. While flooding is an obvious problem ... crawlspaces and unfinished areas dry to avoid a musty ... Damp Basement, Even small amounts of water can cause foundation ...
(Date:5/7/2015)... 07, 2015 Five CHI Health ... Health Bergan Mercy, CHI Health Immanuel and CHI ... in Papillion, Neb.; and CHI Health Mercy in ... achieving high-quality standards of care by the Accreditation ... to best practices in cardiovascular care. The five ...
(Date:5/6/2015)... 2015 Device Patent Law Changes:, Six Key ... a.m. – 12:30 p.m. EDT, http://www.fdanews.com/DevicePatentLaw , Every ... lawsuits and claims that waste their time. , It ... could be prevented if devicemakers better understand the trouble spots ... and revisions to patent laws from all around the world. ...
(Date:5/6/2015)... the exclusive hospital of the Tampa Bay Buccaneers, Florida Hospital ... James Stadium for all the “Bucs Babies” celebrating their first ... the “Bucs Babies” program last year. , “It is ... those born at the Florida Hospitals here in our community, ... enjoyed my time participating in the festivities, interacting with the ...
(Date:5/6/2015)... 06, 2015 On April 27, 2015, ... Plastic Surgery ,” compiled quotes about cosmetic surgery from ... pop singer Iggy Azalea, and Gwyneth Paltrow. For the ... having plastic surgery themselves; only a couple ... its expectations of youth and beauty. (see: goo.gl/wSomih) , ...
Breaking Medicine News(10 mins):Health News:Spring Storms Bring Musty Smell Inside 2Health News:Spring Storms Bring Musty Smell Inside 3Health News:Five CHI Health Facilities in Nebraska, Iowa Recognized for High-Quality Care by Accreditation for Cardiovascular Excellence 2Health News:Five CHI Health Facilities in Nebraska, Iowa Recognized for High-Quality Care by Accreditation for Cardiovascular Excellence 3Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 2Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 3Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2
... 1 Skin damage. If,you are over 40, your skin ... as a smoker (lip lines), those long, lazy sun-worshipping summers,(dry, ... a little more of Mom and Pop in the mirror ... seeing is normal skin aging, but most of it is,likely ...
... to Fujifilm,s ... broad DR product line, STAMFORD, Conn., ... the FDA 510(k) clearance of its newest Fuji DR,(FDR) system, the ... system that can perform a variety of exams with,only one detector. ...
... BOULDER, Colo., Feb. 29 The National Patient,Safety ... Road Taken,Together," stresses the importance of improving healthcare ... and communities., Supporting National Patient Safety Awareness ... (Amex: ECI ) urges communities to,actively partner ...
... the odds? Today, at,Gulf Coast Medical Center in Panama City, ... Year babies. That news may not make,headlines, but consider the ... Joe, Florida and their husbands work together at the,Port St. ... were together helping put out a hotel fire when they ...
... how certain proteins, including,Hax1, work and how ... Tenn., Feb. 29 Investigators at St.,Jude Children,s ... that,protects certain cells from undergoing apoptosis, also known ... apoptosis is important to,researchers seeking ways to control ...
... Plans to Separate Medical ... Funeral Services Businesses, BATESVILLE, Ind., Feb. 29 Hillenbrand,Industries, ... it has,commenced a cash tender offer to purchase any and ... No. 431573AD6), of which $250,million in aggregate principal amount was ...
Cached Medicine News:Health News:The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing 2Health News:The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing 3Health News:The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing 4Health News:Fujifilm Receives FDA Approval for Unity SpeedSuite(TM) 2Health News:Fujifilm Receives FDA Approval for Unity SpeedSuite(TM) 3Health News:Encision Supports National Patient Safety Awareness Week 2Health News:St. Jude Researchers Find Key Step in Programmed Cell Death 2Health News:St. Jude Researchers Find Key Step in Programmed Cell Death 3Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 2Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 3Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 4Health News:Hillenbrand Industries, Inc. Announces 'Any and All' Cash Tender Offer for Its 4.50 percent Senior Notes Due 2009 5
Curved shafts with 2 mm angled platform. Wide serrated handle with dull finish....
Straight shafts with fine tips and dull finish. Insulated stop with tip gap set at 0.3 mm. Smooth handle....
Straight shafts with micro tips and sandblast finish. Insulated smooth handle....
Straight shafts with rounded tips. Smooth handle with dull finish....
Medicine Products: